Alkem Laboratories LtdPharmaceuticalsINE540L01014Consolidated₹5466.50+118.00 (+2.21%)Jun-26
Valuation
Market Cap₹65.36K Cr
TTM PE30.30x
Forward PE35.21x
PEG-4.83
Book Value₹1155.86
P/B4.73x
TTM EPS₹180.44
Fwd EPS₹155.27
TTM Revenue₹15.08K Cr
TTM PAT₹2.20K Cr
TTM EBITDA₹3.03K Cr
TTM EBIT₹2.64K Cr
Last Qtr PAT₹520.98 Cr
Last Qtr EBITDA₹766.05 Cr
Last Qtr EBIT₹665.86 Cr
Profitability
ROE15.95%
ROCE19.22%
TTM NPM14.62%
TTM EBITDA %20.11%
Curr OPM13.38%
Last OPM6.60%
Curr NPM—
Last NPM—
Curr EPS₹43.49
Last EPS₹19.77
Balance sheet
Equity₹23.91 Cr
Reserve₹13.80K Cr
Total Debt₹2,047.16 Cr
D/E0.15x
Interest %8.95%
Curr Interest₹46.62 Cr
Price / range
Close₹5466.50
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.21%
1W+7.45%
1M-0.16%
3M+1.76%
6M+2.20%
1Y-0.22%
2Y-10.26%
3Y+49.42%
5Y+42.92%
Diwali+0.02%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits